Brief: CMS Sets Price For Devyser's Prenataldetect RHD Test At $192
Nov 28 (Reuters) - Devyser Diagnostics AB DVYSR.ST: CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS) SET PRICE FOR DEVYSER'S PRENATALDETECT RHD TEST AT $192 Source text: ID:nMFN6qTQKj Further company coverage: DVYSR.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Devyser Diagnostics AB
See all newsBrief: Devyser Awarded Tender In Italy Valued At SEK 8.9 Million
Brief: Devyser Diagnostics Appoints Niklas Axelsson As CFO
Sweden's Devyser Q1 net sales rise 12.9%, operating profit turns positive
Brief: Devyser Q1 Sales SEK 61.8 Million
Brief: Devyser Completes Cybergene Acquisition, Carries Out Compensation Share Issue